Polymer–drug structures are now known constructs that chemically Mix the bioactive component with a particular area of your polymer to ensure its delivery to the qualified intracellular compartment [1]. numerous synthetic approaches have been revealed to bond the polymer and drug either during the polymer spine or from the facet-chain [2–4]. th